Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,000,074
-
Share change
-
+31,602
-
Total reported value
-
$1,210,194
-
Price per share
-
$1.21
-
Number of holders
-
20
-
Value change
-
+$48,216
-
Number of buys
-
9
-
Number of sells
-
8
Institutional Holders of MIRA PHARMACEUTICALS, INC. - COM (MIRA) as of Q2 2025
As of 30 Jun 2025,
MIRA PHARMACEUTICALS, INC. - COM (MIRA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,000,074 shares.
The largest 10 holders included
Cross Staff Investments Inc, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Suncoast Equity Management, STATE STREET CORP, J.W. COLE ADVISORS, INC., INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Creative Planning, and XTX Topco Ltd.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.